Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 382

1.

General aspects of diabetes mellitus.

Alam U, Asghar O, Azmi S, Malik RA.

Handb Clin Neurol. 2014;126:211-22. doi: 10.1016/B978-0-444-53480-4.00015-1.

PMID:
25410224
[PubMed - in process]
2.

Management of Hepatitis C infection among patients with renal failure.

Latt NL, Araz F, Alachkar N, Durand CM, Gurakar A.

Minerva Gastroenterol Dietol. 2014 Nov 12. [Epub ahead of print]

PMID:
25390288
[PubMed - as supplied by publisher]
3.

Clinical utility of serum beta-2-microglobulin as a predictor of diabetic complications in patients with type 2 diabetes without renal impairment.

Kim MK, Yun KJ, Chun HJ, Jang EH, Han KD, Park YM, Baek KH, Song KH, Cha BY, Park CS, Kwon HS.

Diabetes Metab. 2014 Oct 7. pii: S1262-3636(14)00135-9. doi: 10.1016/j.diabet.2014.08.002. [Epub ahead of print]

PMID:
25303803
[PubMed - as supplied by publisher]
4.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

Himmelfarb J, Tuttle KR.

N Engl J Med. 2014 May 1;370(18):1768-9. No abstract available.

PMID:
24804308
[PubMed - indexed for MEDLINE]
5.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

Ellison DH.

N Engl J Med. 2014 May 1;370(18):1768. doi: 10.1056/NEJMc1400872#SA3. No abstract available.

PMID:
24785223
[PubMed - indexed for MEDLINE]
6.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

Molnár GA, Kovács T, Wittmann I.

N Engl J Med. 2014 May 1;370(18):1767-8. doi: 10.1056/NEJMc1400872#SA2. No abstract available.

PMID:
24785222
[PubMed - indexed for MEDLINE]
7.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

Chartoumpekis DV, Sykiotis GP.

N Engl J Med. 2014 May 1;370(18):1767. doi: 10.1056/NEJMc1400872#SA1. No abstract available.

PMID:
24785221
[PubMed - indexed for MEDLINE]
8.

Bardoxolone methyl in type 2 diabetes and advanced chronic kidney disease.

Chertow GM, de Zeeuw D; BEACON Steering Committee.

N Engl J Med. 2014 May 1;370(18):1768. doi: 10.1056/NEJMc1400872. No abstract available.

PMID:
24785220
[PubMed - indexed for MEDLINE]
Free Article
9.

[Consensus document on treatment of type 2 diabetes in patients with chronic kidney disease].

Gómez-Huelgas R, Martínez-Castelao A, Artola S, Górriz JL, Menéndez E; Grupo de Tabajo para el Documento de Consenso sobre el tratamiento de la diabetes tipo 2 en el paciente con enfermedad renal crónica.

Nefrologia. 2014;34(1):34-45. Spanish.

PMID:
24611186
[PubMed - in process]
10.

Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Grinsztejn B, Hosseinipour MC, Ribaudo HJ, Swindells S, Eron J, Chen YQ, Wang L, Ou SS, Anderson M, McCauley M, Gamble T, Kumarasamy N, Hakim JG, Kumwenda J, Pilotto JH, Godbole SV, Chariyalertsak S, de Melo MG, Mayer KH, Eshleman SH, Piwowar-Manning E, Makhema J, Mills LA, Panchia R, Sanne I, Gallant J, Hoffman I, Taha TE, Nielsen-Saines K, Celentano D, Essex M, Havlir D, Cohen MS; HPTN 052-ACTG Study Team.

Lancet Infect Dis. 2014 Apr;14(4):281-90. doi: 10.1016/S1473-3099(13)70692-3. Epub 2014 Mar 4. Erratum in: Lancet Infect Dis. 2014 Apr;14(4):269.

PMID:
24602844
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Predictors of congestive heart failure after treatment with an endothelin receptor antagonist.

Hoekman J, Lambers Heerspink HJ, Viberti G, Green D, Mann JF, de Zeeuw D.

Clin J Am Soc Nephrol. 2014 Mar;9(3):490-8. doi: 10.2215/CJN.07040713. Epub 2014 Jan 9.

PMID:
24408122
[PubMed - indexed for MEDLINE]
12.

Proteinuric renal disease in type 2 diabetes-is remission of proteinuria associated with improved mortality and morbidity?

Tan J, Jaung R, Gamble G, Cundy T.

Diabetes Res Clin Pract. 2014 Jan;103(1):63-70. doi: 10.1016/j.diabres.2013.11.023. Epub 2013 Dec 6.

PMID:
24380605
[PubMed - indexed for MEDLINE]
13.

The dramatic course of dissection of a giant thoracic aortic aneurysm.

Pietrzyk E, Michta K, Gorczyca-Michta I, Wożakowska-Kapłon B.

Kardiol Pol. 2013;71(11):1208. doi: 10.5603/KP.2013.0308. No abstract available.

PMID:
24297725
[PubMed - indexed for MEDLINE]
Free Article
14.

New therapies for diabetic kidney disease.

Himmelfarb J, Tuttle KR.

N Engl J Med. 2013 Dec 26;369(26):2549-50. doi: 10.1056/NEJMe1313104. Epub 2013 Nov 9. No abstract available.

PMID:
24206460
[PubMed - indexed for MEDLINE]
15.

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

de Zeeuw D, Akizawa T, Audhya P, Bakris GL, Chin M, Christ-Schmidt H, Goldsberry A, Houser M, Krauth M, Lambers Heerspink HJ, McMurray JJ, Meyer CJ, Parving HH, Remuzzi G, Toto RD, Vaziri ND, Wanner C, Wittes J, Wrolstad D, Chertow GM; BEACON Trial Investigators.

N Engl J Med. 2013 Dec 26;369(26):2492-503. doi: 10.1056/NEJMoa1306033. Epub 2013 Nov 9.

PMID:
24206459
[PubMed - indexed for MEDLINE]
Free Article
16.

Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for end-stage renal disease/mortality in type 2 diabetes.

Campbell HM, Khan N, Raisch DW, Borrego ME, Sather MR, Murata GH.

Diabetes Res Clin Pract. 2013 Dec;102(3):233-41. doi: 10.1016/j.diabres.2013.10.005. Epub 2013 Oct 9.

PMID:
24183258
[PubMed - indexed for MEDLINE]
17.

The role of direct renin inhibitors in the treatment of the hypertensive diabetic patient.

Riccioni G.

Ther Adv Endocrinol Metab. 2013 Oct;4(5):139-45. doi: 10.1177/2042018813490779.

PMID:
24143271
[PubMed]
Free PMC Article
18.

25 (OH) vitamin D levels and renal disease progression in patients with type 2 diabetic nephropathy and blockade of the renin-angiotensin system.

Fernández-Juárez G, Luño J, Barrio V, de Vinuesa SG, Praga M, Goicoechea M, Lahera V, Casas L, Oliva J; PRONEDI Study Group.

Clin J Am Soc Nephrol. 2013 Nov;8(11):1870-6. doi: 10.2215/CJN.00910113. Epub 2013 Oct 17.

PMID:
24135218
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

The impact of diabetes mellitus on peritoneal dialysis: the Turkey Multicenter Clinic Study.

Ozener C, Arikan H, Karayaylali I, Utas C, Bozfakioglu S, Akpolat T, Ataman R, Ersoy F, Camsari T, Yavuz M, Akcicek F, Yilmaz ME.

Ren Fail. 2014 Mar;36(2):149-53. doi: 10.3109/0886022X.2013.843275. Epub 2013 Oct 17.

PMID:
24131086
[PubMed - indexed for MEDLINE]
20.

Parameters of glycemic control in type 2 diabetic patients on hemodialysis or peritoneal dialysis: implications for clinical practice.

Pavan MV, Rodrigues CI, D'Ávila R, Guerra EM, Cadaval RA, de Almeida FA.

Arq Bras Endocrinol Metabol. 2013 Aug;57(6):457-63.

PMID:
24030186
[PubMed - indexed for MEDLINE]
Free Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk